April 30 2025 - AstraZeneca’s Truqap fails in another Phase III trial

AstraZeneca’s Truqap fails in another Phase III trial
Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection
Donald Trump’s first 100 days: Impact on the healthcare industry
Merck begins construction on $1B Keytruda manufacturing facility in Delaware
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud